Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket Capitalization

KalVista Pharmaceuticals (KALV) Net Margin: 2014-2020

Historic Net Margin for KalVista Pharmaceuticals (KALV) over the last 6 years, with Apr 2020 value amounting to -224.74%.

  • KalVista Pharmaceuticals' Net Margin rose 14707.00% to -224.74% in Q2 2020 from the same period last year, while for Apr 2020 it was -305.00%, marking a year-over-year decrease of 12873.00%. This contributed to the annual value of 3,171.17% for FY2025, which is 342445.00% up from last year.
  • According to the latest figures from Q2 2020, KalVista Pharmaceuticals' Net Margin is -224.74%, which was up 71.31% from -783.26% recorded in Q1 2020.
  • KalVista Pharmaceuticals' 5-year Net Margin high stood at -13.57% for Q2 2018, and its period low was -94,342.86% during Q1 2016.
  • For the 3-year period, KalVista Pharmaceuticals' Net Margin averaged around -253.10%, with its median value being -224.31% (2019).
  • In the last 5 years, KalVista Pharmaceuticals' Net Margin plummeted by 2,028,571bps in 2016 and then skyrocketed by 494,721bps in 2018.
  • KalVista Pharmaceuticals' Net Margin (Quarterly) stood at -2,152.79% in 2016, then surged by 171,038bps to -442.41% in 2017, then soared by 35,856bps to -83.85% in 2018, then tumbled by 14,023bps to -224.08% in 2019, then spiked by 14,707bps to -224.74% in 2020.
  • Its Net Margin was -224.74% in Q2 2020, compared to -783.26% in Q1 2020 and -224.08% in Q4 2019.